Trial intelligence / Profile preview

Topical bimiralisib proof-of-concept study in healthy volunteers and mycosis fungoides patients

NL-OMON48135Completed

Sponsor
PIQUR Therapeutics AG
Start
Jul 2019
Countries
1
01

Overview

Trial, sponsored by PIQUR Therapeutics AG. Started Jul 2019; status: completed.

Beyond the preview

Go deeper on NL-OMON48135.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON48135.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call